To understand the biology of hormone refractory prostate cancer, it is crit
ical to understand both the cellular organization of the normal prostate an
d how normal prostate epithelial cells respond to androgen. Recent studies
have demonstrated that the normal prostate is heterogenous, composed of ste
m cell units hierarchically containing androgen-independent stem cells, and
rogen-sensitive amplifying cells, and androgen-dependent transit epithelial
cells. This article discusses the relationship between the specific cell.
of origin for prostate cancer and the resulting androgen responsiveness of
the cancer. In addition, various genetic and epigenetic mechanisms for the
initial development and eventual clonal selection of androgen-sensitive and
androgen-independent cancer cells from initially androgen-dependent prosta
te cancer cells are presented. Therapeutic implications for such tumor cell
heterogeneity and clonal selection are discussed.